Literature DB >> 10553822

The influence of different intravascular volume replacement regimens on renal function in the elderly.

B Kumle1, J Boldt, S Piper, C Schmidt, S Suttner, S Salopek.   

Abstract

UNLABELLED: Elderly patients are at risk of developing renal dysfunction. Synthetic colloids are often used perioperatively, but they may have detrimental effects on renal function. In a prospective, randomized study, we assessed the influence of different intravascular volume replacement regimens on renal function in elderly (>65 yr) and younger (< 65 yr) patients without preoperative renal dysfunction who were undergoing major abdominal surgery. Either 6% low molecular weight hydroxyethyl starch (HES) solution (mean molecular weight 70,000 D, degree of substitution 0.5; HES 70/0.5) [each group n = 10]), 6% medium-molecular weight HES (molecular weight 200,000 D, degree of substitution 0.5 (HES 200/0.5) [each group n = 10]), or modified gelatin (molecular weight 35,000 D [each group n = 10]) was administered to maintain mean arterial blood pressure >65 mm Hg and central venous pressure between 10 and 14 mm Hg. After the induction of anesthesia (T0); at the end of surgery (T1); 4 h after surgery (T2); and on the first (T3), second (T4), and third postoperative days (T5), alpha1-microglobulin (alpha1-M), N-acetyl-beta-glucosaminidase, fractional sodium clearance, and creatinine clearance (CC) were measured. Colloids (1300-3000 mL) were infused until the first postoperative day. At T0, urine concentrations of alpha1-M were higher in the elderly than in the younger patients in all groups (P < 0.05). alpha1-M remained increased only in the gelatin group. N-acetyl-beta-glucosaminidase and fractional sodium clearance were not affected during the study period in any groups. At baseline, CC was significantly higher in the younger than in the elderly patients, but CC did not decrease in any of the intravascular volume replacement groups. We conclude that intravascular volume therapy with gelatin and two different HES preparations did not adversely affect renal function in elderly patients without preoperative renal malfunction. IMPLICATIONS: We studied the influence of three different intravascular volume replacement regimens on renal function in elderly patients without renal dysfunction who were undergoing major abdominal surgery. Two hydroxyethyl starch and one gelatin preparation were administered perioperatively to maintain stable hemodynamics. As assessed by sensitive markers of renal function, all three regimens can be used safely for volume replacement without risking significant renal dysfunction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10553822

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  15 in total

1.  Renal impairment in cardiac surgery patients receiving hydroxyethyl starch.

Authors:  Christian J Wiedermann
Journal:  Intensive Care Med       Date:  2004-01-16       Impact factor: 17.440

Review 2.  Pharmacokinetics of hydroxyethyl starch.

Authors:  Cornelius Jungheinrich; Thomas A Neff
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

3.  Pharmacodynamics and organ storage of hydroxyethyl starch in acute hemodilution in pigs: influence of molecular weight and degree of substitution.

Authors:  Christoph Eisenbach; Alexander H Schönfeld; Norbert Vogt; Moritz N Wente; Jens Encke; Wolfgang Stremmel; Eike Martin; Ernst Pfenninger; Markus A Weigand
Journal:  Intensive Care Med       Date:  2007-06-07       Impact factor: 17.440

Review 4.  Colloid solutions: a clinical update.

Authors:  Tomi T Niemi; Ryo Miyashita; Michiaki Yamakage
Journal:  J Anesth       Date:  2010-10-17       Impact factor: 2.078

Review 5.  Hydroxyethylstarch as a risk factor for acute renal failure: is a change of clinical practice indicated?

Authors:  Joachim Boldt
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

6.  Update on transfusion solutions during surgery: review of hydroxyethyl starches 130/0.4.

Authors:  Ornella Piazza; Giuliana Scarpati; Rosalba Tufano
Journal:  Int J Gen Med       Date:  2010-10-05

7.  Effects of a predominantly hydroxyethyl starch (HES)-based and a predominantly non HES-based fluid therapy on renal function in surgical ICU patients.

Authors:  Franziska Schabinski; Janaina Oishi; Fabio Tuche; Alain Luy; Yasser Sakr; Donald Bredle; Christiane Hartog; Konrad Reinhart
Journal:  Intensive Care Med       Date:  2009-06-17       Impact factor: 17.440

8.  The risk associated with hyperoncotic colloids in patients with shock.

Authors:  Frédérique Schortgen; Emmanuelle Girou; Nicolas Deye; Laurent Brochard
Journal:  Intensive Care Med       Date:  2008-08-07       Impact factor: 17.440

9.  Influence of low-molecular-weight hydroxyethyl starch on microvascular permeability in patients undergoing abdominal surgery: comparison with crystalloid.

Authors:  Yuko Ando; Yoshiaki Terao; Makoto Fukusaki; Kazunori Yamashita; Masafumi Takada; Takahiro Tanabe; Koji Sumikawa
Journal:  J Anesth       Date:  2008-11-15       Impact factor: 2.078

Review 10.  Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis.

Authors:  Nicolai Haase; Anders Perner; Louise Inkeri Hennings; Martin Siegemund; Bo Lauridsen; Mik Wetterslev; Jørn Wetterslev
Journal:  BMJ       Date:  2013-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.